Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters.

Rao PJ, Vardhini NV, Parvathi MV, Murthy PB, Sudhakar G.

Tumour Biol. 2014 Oct;35(10):9539-48. doi: 10.1007/s13277-014-1909-x. Epub 2014 Jun 24.

PMID:
24957039
2.

Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.

Rhoden KJ, Johnson C, Brandao G, Howe JG, Smith BR, Tallini G.

Lab Invest. 2004 Dec;84(12):1557-70.

3.

Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.

Liu RT, Chou FF, Wang CH, Lin CL, Chao FP, Chung JC, Huang CC, Wang PW, Cheng JT.

Thyroid. 2005 Apr;15(4):326-35.

PMID:
15876154
4.

Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma.

Dinets A, Hulchiy M, Sofiadis A, Ghaderi M, Höög A, Larsson C, Zedenius J.

Eur J Endocrinol. 2012 Jun;166(6):1049-60. doi: 10.1530/EJE-12-0144. Epub 2012 Mar 28.

5.

RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).

Nakazawa T, Kondo T, Kobayashi Y, Takamura N, Murata S, Kameyama K, Muramatsu A, Ito K, Kobayashi M, Katoh R.

Cancer. 2005 Sep 1;104(5):943-51.

6.

Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas.

Puxeddu E, Moretti S, Giannico A, Martinelli M, Marino C, Avenia N, Cristofani R, Farabi R, Reboldi G, Ribacchi R, Pontecorvi A, Santeusanio F.

Eur J Endocrinol. 2003 May;148(5):505-13.

7.

[The correlation between BRAF mutations, RET/PTC rearrangements and platelet-derived growth factor B expression in papillary thyroid carcinomas].

Wang P, Wang YG, Zhao WJ, Fu YD, Wang L, Wang F, Zhao SH.

Zhonghua Nei Ke Za Zhi. 2012 Dec;51(12):987-91. Chinese.

PMID:
23327964
8.

Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.

Brzeziańska E, Karbownik M, Migdalska-Sek M, Pastuszak-Lewandoska D, Włoch J, Lewiński A.

Mutat Res. 2006 Jul 25;599(1-2):26-35. Epub 2006 Feb 17.

PMID:
16483615
9.

The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.

Erdoğan M, Berdeli A, Karadeniz M, Ertan Y, Cetinkalp S, Saygili F, Tuncyurek M, Yilmaz C, Tuzun M, Kabalak T, Uluer H, Ozgen AG.

Exp Clin Endocrinol Diabetes. 2008 Apr;116(4):225-30. doi: 10.1055/s-2007-992153.

PMID:
18393128
10.

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.

Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M.

Am J Pathol. 2002 Jan;160(1):247-54.

11.

[Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].

Vasil'ev EV, Rumiantsev PO, Saenko VA, Il'in AA, Poliakova EIu, Nemtsova MV, Zaletaev DV.

Mol Biol (Mosk). 2004 Jul-Aug;38(4):642-53. Russian.

PMID:
15456136
12.

[Expressions of wildtype-RET and RET/PTC rearrangements in sporadic adult papillary thyroid carcinoma and their clinicopathologic correlation].

Zhu XL, Zhou XY, Zhang TM, Zhu XZ.

Zhonghua Bing Li Xue Za Zhi. 2006 Feb;35(2):87-91. Chinese.

PMID:
16630482
13.
14.

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.

Romei C, Elisei R.

Front Endocrinol (Lausanne). 2012 Apr 11;3:54. doi: 10.3389/fendo.2012.00054. eCollection 2012.

15.

Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.

Mechler C, Bounacer A, Suarez H, Saint Frison M, Magois C, Aillet G, Gaulier A.

Br J Cancer. 2001 Dec 14;85(12):1831-7.

16.

High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas.

Lam KY, Lo CY, Leung PS.

Eur J Endocrinol. 2002 Dec;147(6):741-5.

17.

Assessment of RET/PTC1 and RET/PTC3 rearrangements in fine-needle aspiration biopsy specimens collected from patients with Hashimoto's thyroiditis.

Cyniak-Magierska A, Wojciechowska-Durczyńska K, Krawczyk-Rusiecka K, Zygmunt A, Lewiński A.

Thyroid Res. 2011 Jan 10;4(1):5. doi: 10.1186/1756-6614-4-5.

18.

High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.

Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, Cherstvoy ED, Tronko ND, Bogdanova TI, Chiappetta G, Viglietto G, Pentimalli F, Salvatore G, Fusco A, Santoro M, Vecchio G.

J Clin Endocrinol Metab. 1999 Nov;84(11):4232-8.

PMID:
10566678
19.

RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation.

Nakazawa T, Murata S, Kondo T, Niu D, Mochizuki K, Kawasaki T, Yamane T, Nakamura N, Katoh R.

Virchows Arch. 2009 Jul;455(1):35-41. doi: 10.1007/s00428-009-0789-8. Epub 2009 Jun 3.

PMID:
19495791
20.

Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.

Smida J, Salassidis K, Hieber L, Zitzelsberger H, Kellerer AM, Demidchik EP, Negele T, Spelsberg F, Lengfelder E, Werner M, Bauchinger M.

Int J Cancer. 1999 Jan 5;80(1):32-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk